NOFO: Applied Regulatory Science Research to evaluate Cardiotoxicity of Oncology Therapeutics Clinical Trial Optional (US)

This Notice of Funding Opportunity (NOFO) support applied regulatory science research to improve the detection and monitoring of cardiotoxicity of oncology therapeutics. Goals This funding opportunity seeks to advance applied regulatory science research aimed at improving the detection and monitoring of cardiotoxicity associated with oncology therapeutics. These goals align with the FDA Oncology Center of

Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members:

Subscribe Now

Scroll to Top